Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
Oncology Today with Dr Neil Love · Dr. Neil Love
October 11, 202346m 28s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
CME information and select publications here